Gyre Therapeutics (GYRE) Change in Taxes (2023 - 2026)
Gyre Therapeutics (GYRE) reported Change in Taxes of $144000.0 for Q1 2026, up 106.35% year-over-year from $69782.7 in Q1 2025, and down 44.83% quarter-over-quarter from $261000.0 in Q4 2025.
Gyre Therapeutics (GYRE) Change in Taxes (2023 - 2026) Analysis & Trends
Gyre Therapeutics (GYRE) has 4 years of Change in Taxes data on file, last reported at $144000.0 in Q1 2026.
- Change in Taxes for Q1 2026 came in at $144000.0, up 106.35% year-over-year; the trailing twelve-month figure through Mar 2026 was $2.5 million (up 141.91% YoY), and the FY2025 annual result was $44000.0, up 102.03% from the prior year.
- Change in Taxes fell to $144000.0 in Q1 2026 per GYRE's latest filing, from $261000.0 in the prior quarter.
- Over five years, Change in Taxes peaked at $2.5 million in Q3 2023 and troughed at -$4.2 million in Q2 2024.
- A 4-year average of $78846.2 and a median of $261000.0 in 2025 frame the typical range for Change in Taxes.
- On a YoY basis, Change in Taxes climbed as much as 301.54% in 2025 and fell as far as 259.24% in 2025.
- A 4-year view of Change in Taxes shows it stood at -$185000.0 in 2023, then jumped by 135.14% to $65000.0 in 2024, then soared by 301.54% to $261000.0 in 2025, then tumbled by 44.83% to $144000.0 in 2026.
- Business Quant data shows GYRE's Change in Taxes at $144000.0 in Q1 2026, $261000.0 in Q4 2025, and $1.5 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | - |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | - |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Gyre Therapeutics | 554.75 Mn | 540.62 Mn | 8.38 Mn | 144,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 144,000.00 |
| Mar 31, 2026 | 144,000.00 |
| Dec 31, 2025 | 261,000.00 |
| Dec 31, 2025 | 261,000.00 |
| Sep 30, 2025 | 1.54 Mn |
| Sep 30, 2025 | 1.54 Mn |
| Jun 30, 2025 | 513,000.00 |
| Jun 30, 2025 | 513,000.00 |
| Mar 31, 2025 | -2.27 Mn |
| Mar 31, 2025 | -2.27 Mn |
| Dec 31, 2024 | 65,000.00 |
| Dec 31, 2024 | 65,000.00 |
| Sep 30, 2024 | 535,000.00 |
| Sep 30, 2024 | 535,000.00 |
| Jun 30, 2024 | -4.19 Mn |
| Jun 30, 2024 | -4.19 Mn |
| Mar 31, 2024 | 1.42 Mn |
| Mar 31, 2024 | 1.42 Mn |
| Dec 31, 2023 | -185,000.00 |
| Dec 31, 2023 | -185,000.00 |